Evidence map›Paper›PMID 34810045›Full record

ArticleEuropean journal of cancer (Oxford, England : 1990)2022

Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy.

Sakina Sekkate, Henri-Corto Stoeklé, May Mabro, David Billard, Titouan Kennel, Marc Vasse, Christian Hervé, Philippe Beuzeboc

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of cancer (Oxford, England : 1990), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sakina SekkateOncology and Supportive Care Department, Foch Hospital, Suresnes, France.
Henri-Corto StoekléDepartment of Ethics and Scientific Integrity, Foch Hospital, Suresnes, France.
May MabroOncology and Supportive Care Department, Foch Hospital, Suresnes, France.
David BillardOncology and Supportive Care Department, Foch Hospital, Suresnes, France.
Titouan KennelDepartment of Clinical Research and Innovation, Foch Hospital, Suresnes, France.
Marc VasseBiology Department, Foch Hospital, Suresnes, France; UMR-S 1176, Le Kremlin-Bicêtre, France.
Christian HervéDepartment of Ethics and Scientific Integrity, Foch Hospital, Suresnes, France; University of Paris, Paris, France; Veterinary Academy of France, Paris, France; International Academy of Medical Ethics and Public Health, University of Paris, Paris, France.
Philippe BeuzebocOncology and Supportive Care Department, Foch Hospital, Suresnes, France. Electronic address: p.beuzeboc@hopital-foch.com.
Hôpital Foch · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19LymphopeniaNeoplasmsVaccinesBNT162 VaccineHumansSARS-CoV-2VaccinationBNT162 VaccineVaccines

Identifiers

PMID34810045
PMCPMC8552578
OpenAlexW3208395787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.